HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combining gene and immunotherapy for prostate cancer.

Abstract
The nitroreductase (NR)/CB1954 enzyme prodrug system has given promising results in pre-clinical studies and is currently being assessed in phase I and II clinical trials in prostate cancer. Enhanced cell killing by apparent immune-mediated mechanisms has been shown in pancreatic and colorectal cancer models, by co-expressing murine granulocyte macrophage colony-stimulating factor (GM-CSF) with NR in a single replication deficient adenoviral vector. This consists of the CMV immediate early promotor driving expression of NR, with an internal ribosome entry site (IRES) and the gene for murine GM-CSF (mGM-CSF). To examine if similar enhancement of tumour cell killing could be produced in prostate cancer, the TRAMP model was chosen. Results illustrate that the combination of suicide gene therapy using NR and CB1954, with cytokine stimulation with mGM-CSF gives an improved response compared with either modality alone. The mechanism of this improved response is however likely to be non-immune based as it lacks a memory effect.
AuthorsJ G Young, N K Green, V Mautner, P F Searle, L S Young, N D James
JournalProstate cancer and prostatic diseases (Prostate Cancer Prostatic Dis) Vol. 11 Issue 2 Pg. 187-93 ( 2008) ISSN: 1476-5608 [Electronic] England
PMID17726452 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Aziridines
  • Escherichia coli Proteins
  • Prodrugs
  • Recombinant Proteins
  • tretazicar
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • NfsA protein, E coli
  • Nitroreductases
Topics
  • Adenocarcinoma (genetics, immunology, therapy)
  • Adenoviridae (genetics)
  • Animals
  • Antineoplastic Agents (pharmacokinetics, therapeutic use, toxicity)
  • Aziridines (pharmacokinetics, therapeutic use, toxicity)
  • Biotransformation
  • Combined Modality Therapy
  • Defective Viruses (genetics)
  • Escherichia coli Proteins (genetics, metabolism)
  • Genes, Synthetic
  • Genes, Transgenic, Suicide
  • Genetic Therapy (methods)
  • Genetic Vectors (therapeutic use)
  • Granulocyte-Macrophage Colony-Stimulating Factor (genetics, therapeutic use)
  • Immunotherapy (methods)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neoplasm Transplantation
  • Nitroreductases (genetics, metabolism)
  • Prodrugs (pharmacokinetics, therapeutic use)
  • Prostatic Neoplasms (genetics, immunology, therapy)
  • Recombinant Proteins
  • Specific Pathogen-Free Organisms

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: